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Abstract
Glycation, the non-enzymic reaction of sugars with proteins, has an important role in the complications of diabetes. It has
been studied mostly in structural proteins but more recently has been shown to inactivate enzymes. Previous evidence from
our laboratory indicated that glycation-induced inactivation and loss of antigenicity of catalase and superoxide dismutase are
simultaneous. Esterase, which decreases activity in the lens in senile cataract and diabetes, was measured by a spectro-
photometric assay using p-nitrophenyl acetate as the substrate. Here we investigated the inactivation of carboxylesterase (EC
3.1.1.1) by sugars of different glycating power and prednisolone-21-hemisuccinate while simultaneously monitoring the loss
of antigenicity. Antigenicity was assessed by immunoprecipitation and by dot-blotting the glycated and non-glycated
fractions of enzymes separated by affinity chromatography. Ribose and fructose inactivated more rapidly than glucose and
glucose 6-phosphate. The esterase was progressively inactivated by prednisolone-21-hemisuccinate at a lower concentration.
Activity and antigenicity were lost simultaneously. The glycated enzyme had entirely lost its antigenicity. These results
further support the idea that inactivation of enzyme and loss of antigenicity are simultaneous. ß 1999 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Four types of esterase activity occur in mammali-
an serum: pseudocholinesterase, carboxylesterase, ar-
ylesterase and paraoxonase [1]. Esterase activity is
abundant in human monocytes, present in T-lym-
phocytes and equally divided between CD4 and
CD8 T-lymphocyte subsets. It is expressed in human
liver, colon, stomach, breast and brain tissues [2].
Sequence analysis of human liver carboxylesterase
revealed two di¡erent iso-types. It inhibited the in-
vasion of Plasmodium falciparum sporozoites into
primary human hepatocytes [3].
Carboxylesterase is important in detoxi¢cation
and extracellular surfactant metabolism [4^8]. The
K-naphthyl-acetate-esterase activity of peripheral
blood lymphocytes, signi¢cantly reduced in diabetic
patients as compared to controls, was related to the
decreased cell-mediated immunity and the enhanced
risk of infections in these patients [9]. The plasma
levels of esterase was decreased in diabetic patients
[10] and streptozotocin-diabetic rats [11]. Acetylcho-
linesterase activity of the erythrocyte membrane is
signi¢cantly reduced in alloxan-induced diabetes in
rats [12].
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Esterase activity increases with age in some tissues
[2]. The carboxylesterase activity in plasma increased
from negligible (5 days old) to adult male value (31
days old), and in liver increased markedly during the
same period [13].
Two fractions of esterase, with molecular masses
approximately 200 kDa (esterase-I) and 30 kDa (es-
terase-II), were partially puri¢ed from the soluble
fraction of a normal human lens [14]. The activity
of esterase was decreased in the senile cataractous
lens compared to a normal lens of a similar age,
suggesting that esterase plays a role in cataracto-
genesis, unless cataract formation has a deleterious
e¡ect on the catalytic activity of esterase in the lens
[14].
The post-translational modi¢cation of structural
proteins has been widely studied as a possible mech-
anism in the long-term complications of diabetes and
cataracts. Clearly cataracts qualify as a conforma-
tional disease. The conformational change leads to
the formation of aggregates which scatter light to
produce opaci¢cation [15]. Glycation, the reaction
of protein with sugars, is an age-dependent process
thought to be important in all diabetic complica-
tions. The steroid-induced cataract is well known
and is positively correlated with the average annual
dosage of corticosteroids, although a clear correla-
tion between the duration of treatment or dosage
and the incidence of opacity has not emerged
[16,17]. The prevailing hypothesis involves the forma-
tion of a Schi¡ base between the steroid C-20 car-
bonyl group and O-amino groups of crystallin lysine
residues. The mechanism of steroid cataract forma-
tion holds that glucocorticoids are covalently bound
to lens proteins resulting in the destabilisation of the
protein structure allowing further modi¢cation lead-
ing to cataract. Mechanisms other than the covalent
binding of steroids to lens proteins may have a role
in glucocorticoid-induced cataracts [18]. Sugars and
corticosteroids react with lysine residues of protein
eliminating its charge [19], and inactivate important
metabolic enzymes in the lens.
Glycation-induced inactivation and loss of antige-
nicity of superoxide dismutase and catalase occur
simultaneously [20]. The glycation and inactivation
of enzymes could be accompanied by an accumula-
tion of antigenically reactive but catalytically im-
paired enzyme molecules. Either the enzyme lost its
enzymic activity but still retained its antigenicity, or
it lost both enzymic and antigenic sites.
The objective of the current study was to deter-
mine if inactivation of esterase by sugars (ribose,
fructose, glucose 6-phosphate and glucose) and pred-
nisolone-21-hemisuccinate, was simultaneous with
the loss of antigenicity.
2. Materials and methods
2.1. Materials
Esterase (porcine liver, carboxylic ester hydrolase
from porcine liver, EC 3.1.1.1), ribose, fructose, glu-
cose 6-phosphate (G6P), glucose, prednisolone-21-
hemisuccinate (P-21-H), p-nitrophenyl acetate
(PNPA) and acetonitrile were obtained from Sigma
(Poole, Dorset, UK). Sephacryl S-300HR was pur-
chased from Pharmacia (Milton Keynes, UK). Rab-
bit anti-esterase (porcine liver) polyclonal antibody
(catalog number AB1217, lot number 16395023)
and Promega kit were obtained from Chemicon In-
ternational. A⁄-Gel 601 (boronate-derivatised poly-
acrylamide gel) was from Bio-Rad Laboratories.
2.2. Incubation with sugars and P-21-H
Esterase (5 U/30.3 Wg) was incubated in a shaking
water bath at 37‡C in 50 mM sodium phosphate
bu¡er, pH 6.79, with or without 20 mM ribose, fruc-
tose, G6P, glucose and 1 mM P-21-H for 0^13 days
in a ¢nal volume of 10 ml. Stock solutions were
divided into separate small sterilised glass vials with
rubber tops (Whatman) through a sterilised Milli-
pore ¢lter (0.2 Wm pore size). Individual vials were
removed at zero time and various times thereafter for
assay in triplicate.
2.3. Esterase assay
The enzyme activity was assayed by monitoring
the rate of PNPA hydrolysis catalysed by porcine
liver esterase using a Hitachi U-2001 spectrophotom-
eter [21]. The PNPA was dissolved in acetonitrile to
make a stock solution (60 mM) to prevent slow hy-
drolysis in water and to achieve higher concentra-
tions of PNPA in the reaction solution. A 1 ml ali-
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quot of the PNPA solution was diluted with 19 ml
sodium phosphate bu¡er (50 mM, pH 6.79, ionic
strength as 0.5 with NaCl) just before the assay.
Then 1 ml of this diluted PNPA solution and
0.2 ml of enzyme solution were mixed in a 1.4 ml
cuvette for reaction compared against a phosphate
bu¡er blank reference to subtract non-enzymatic
background hydrolysis at 28‡C. The rate of the en-
zymatic hydrolysis was followed at 400 nm for a
standard period of 100 s with a lag of 30 s at the
beginning of the reaction. Rates were calculated from
the p-nitrophenol absorbance data beginning 30 s
after the reaction had started, with measurements
at 5 s intervals for 70 s. Activity is expressed relative
to the control activity at each respective incubation
time, set at 100%.
2.4. Immunoprecipitation
Immunoprecipitation experiments were used as de-
scribed [20]. Firstly the amounts of antibody that
were su⁄cient to precipitate approximately 50% of
the activity of a ¢xed amount of enzyme during in-
cubation were determined. Various amounts of anti-
body (ranging from 0 to 50 Wl) were added to prep-
arations of esterase (3.03 Wg/ml) in a total volume
0.6 ml. The mixtures were adjusted to a constant
volume with 50 mM sodium phosphate bu¡er, pH
6.79. After incubation overnight at 4‡C, the mixtures
were centrifuged at 3000Ug for 30 min and the re-
sidual activity in the supernatant was assayed. The
50 mM sodium phosphate bu¡ers replaced antiserum
as the control. Then, antibody solution (1:4) ranging
from 15 to 30 Wl was mixed with preparations of
esterase (3.03 Wg/ml) during incubation with 20 mM
ribose, fructose, G6P, glucose and 1 mM P-21-H.
2.5. A⁄nity chromatography of glycated enzymes
Glycated and non-glycated esterase taken from the
incubation medium after the remaining activity was
approximately 50% compared with the control, were
separated on a pre-equilibrated A⁄-Gel 601 column.
A⁄-Gel 601 boronate-derivatised polyacrylamide gel
has an a⁄nity for coplanar adjacent cis-hydroxyl
groups (cis-diols), which provides highly e⁄cient sep-
aration of low molecular weight compounds such as
nucleotides, nucleosides, catecholamines and sugars.
A column (1U13 cm2) was packed with aminoethyl
succinyl aminophenylboronate covalently attached to
the matrix. The sample was loaded into 0.25 M am-
monium acetate bu¡er, pH 8.5, which was used for
column equilibration and for eluting non-glycated
proteins at a rate of approximately 25 ml/h. After
this the column was eluted sequentially with 0.1 M
and 0.3 M acetic acid (30 ml of each). Fractions of
2.2 ml were collected, 20 Wl of each was taken for
measurement of esterase activity. Fractions contrib-
uting to activity peaks were concentrated by rotary
evaporation and diluted by PBS, then concentrated
again. After most bound proteins had been eluted,
0.5 M acetic acid was used to regenerate the column.
2.6. Determination of protein concentration
Protein concentrations were determined by Brad-
ford protein assay with Coomassie blue using bovine
plasma albumin as a standard [22]. To 50 Wl of
standards was added 2.5 ml Coomassie blue protein
reagent and mixture, the absorbance at 595 nm was
measured after 10 min. A standard protein curve was
constructed by absorbance at 595 nm. Then samples
were prepared by dissolving in 1 M NaOH and
treated as above.
2.7. Dot-blotting
Dot-blotting was performed as described [20]. The
sample for blotting was applied as a dot to a sheet of
nitrocellulose which was treated ¢rst with 10% etha-
nol, then it was blocked by incubation for 1 h at
37‡C in PBS/milk. Following the blocking step the
nitrocellulose was washed at least three times in a
fresh solution of PBS/Tween (0.2% Tween 80 in
PBS). The nitrocellulose was then incubated in
PBS/milk containing antiserum to esterase (1:1000)
for 1 h at 37‡C. After careful washing, anti-rabbit
conjugate was bound by incubating the nitrocellulose
for 1 h at 37‡C in a 1/7500 dilution of Promega anti-
rabbit serum in PBS/milk. Following incubation the
nitrocellulose was washed 3^6 times in PBS/Tween,
and incubated at room temperature in the dark in
colour development reagent solution (26.4 Wl of NBT
and 13.2 Wl of BCIP were added to 4 ml of reaction
bu¡er (100 mM Tris-HCl, pH 9.5, 100 mM NaCl,
5 mM MgCl2) as described in the Promega kit) for
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20 min. When colour development was complete the
nitrocellulose was rinsed in PBS and dried on ¢lter
paper. Photographs were taken later.
2.8. Analysis
Statistical analysis was performed using Student’s
paired t-test.
3. Results
3.1. Inactivation and loss of antigenicity of esterase
The extent of the loss of antigenicity was deter-
mined by the immunoprecipitation of esterase with
polyclonal antibody to esterase in which the concen-
tration (1:4) of antibody was su⁄cient to precipitate
esterase activity. There was 82.7 þ 8.9%, 75.3 þ 6.8%,
65.3 þ 9.5%, 28.0 þ 5.0% and 21.2 þ 4.2% of activity
remaining after immunoprecipitation with 20, 25,
27, 30, 35 Wl of antibody respectively (Fig. 1). About
27 Wl of antibody was required to precipitate 60% of
the activity.
The esterase was inactivated over 4 days incuba-
tion with ribose (Fig. 2). The antibody precipitated
approximately a further 37.5%, 32.5%, 17.9% and
9.9% of activity after 1, 2, 3 and 4 days respectively.
Fig. 3. Fructose-induced inactivation of esterase. During incu-
bation with 20 mM fructose samples were taken for immuno-
precipitation with antibody of esterase. Activity was measured
before and after immunoprecipitation. F = fructose.
Fig. 2. Ribose-induced inactivation of esterase. During incuba-
tion with 20 mM ribose samples were taken for immunoprecipi-
tation with antibody of esterase. Activity was measured before
and after immunoprecipitation. R = ribose.
Fig. 1. Immunoprecipitation of esterase. Various amounts of
antibody antiserum (ranging from 20 to 35 Wl, at 1:4 concentra-
tion) were added to preparations of esterase (3.03 Wg/ml) in a
total volume of 0.6 ml. The remaining activity of esterase was
measured and compared with control after immunoprecipita-
tion.
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Up to day 2 the same amount of antibody precipi-
tated an equal amount of activity, suggesting that the
antibody was precipitating only an active enzyme.
The course of inactivation was similar with fructose.
27 Wl of antibody precipitated approximately 47.8%,
46.0% 29.4% and 30.6% after 1, 2, 3 and 4 days
incubation with fructose (Fig. 3). This unchanging
precipitation showed that the antibody precipitated
only an active enzyme, indicating that activity and
antigenicity were lost simultaneously. If the inacti-
vated enzyme had retained its antigenicity, the anti-
body would have precipitated an inactive as well as
an active enzyme and the two lines would not have
stayed parallel, but would have converged continu-
ously.
Glucose 6-phosphate and glucose inactivated ester-
ase more slowly than ribose and fructose. The
amounts of activity precipitated by 27 Wl were
37.2%, 46.9%, 48.9%, 45.3% and 33.5% after 1, 4,
7, 9 and 13 days incubation with G6P respectively
(Fig. 4). It stayed constant at 35^45% up to 9 days.
With glucose the precipitated activities were 41.7%,
44.0%, 48.1% and 47.3% after 4, 7, 9 and 13 days
incubation respectively, indicating that esterase lost
activity and antigenicity simultaneously (Fig. 5).
3.2. The antigenicity of glycated and non-glycated
enzymes
The esterase preparations incubated with ribose
(58.4 þ 7.3% activity remaining), fructose (49.0 þ
Fig. 6. Isolation of control esterase by a⁄nity chromatography
on A⁄-Gel 601. A = 0.1 M glacial acetic acid; B = 0.5 M acetic
acid.
Fig. 5. Immunoprecipitation during inactivation of esterase by
glucose. During incubation with 20 mM glucose samples were
taken for immunoprecipitation with an antibody of esterase.
Activity was measured before and after immunoprecipitation.
Glc = glucose.
Fig. 4. Immunoprecipitation during inactivation of esterase by
G6P. During incubation with 20 mM G6P samples were taken
for immunoprecipitation with an antibody of esterase. Activity
was measured before and after immunoprecipitation.
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3.5%), G6P (67.6 þ 3.3%) and glucose (51.2 þ 1.1%)
were separated by a⁄nity chromatography into
bound and unbound fractions. The amounts of
non-glycated fractions were over twice those of gly-
cated fractions by protein assays. A⁄nity chroma-
tography of the non-incubated enzyme gave a single
main peak, containing the non-glycated enzyme (Fig.
6). After elution by 0.1 M and 0.3 M acetic acid,
there were no further marked peaks of activity
from the incubated samples (Fig. 7; results shown
for the ribose incubation, incubations with the other
sugars gave very similar results).
Samples of the glycated and non-glycated fractions
were dot-blotted. All the unbound fractions (non-
glycated) gave a positive reaction with the anti-ester-
ase, but the bound fractions (glycated) were negative
(Fig. 8). On each blot BSA was run as a negative
control at top left; the other two dots on the left
were two fractions of the unbound protein (non-gly-
cated) after esterase was incubated with 20 mM ri-
bose (R), 20 mM fructose (F), 20 mM G6P and
glucose (Glc) respectively. All the unbound fractions
gave clear positive dots. The right-hand side had the
bound fractions eluted with 0.1 and 0.3 M acetic acid
(top and middle respectively). All of them were neg-
ative; weak marks for bound fractions were caused
by pipette marks in the nitrocellulose layer. The bot-
tom right dot was esterase itself which gave a strong
spot compared to BSA and unbound proteins. It
appears that glycated esterase lost its antigenicity.
The dot-blotting shows clearly that the glycated en-
zyme entirely lost its antigenicity compared with
non-glycated enzyme (Fig. 8).
4. Discussion
Esterase has been considered to be linked with
diabetes and ageing because of its decreased activity
Fig. 8. Dot-blotting of glycated and non-glycated esterase incu-
bated with 20 mM ribose (R), 20 mM fructose (F), 20 mM
G6P and glucose (Glc) ; and the control incubation (C). All
dot-blottings were incubated with anti-esterase. On each blot
BSA was run as a negative control at top left ; the other two
dots on the left were two fractions of the unbound protein,
main peak and tail ; the right-hand side had the bound fractions
eluted with 0.1 and 0.3 M acetic acid (top and middle respec-
tively). The bottom right dot was esterase itself. Weak marks
for bound fractions were caused by pipette marks in the nitro-
cellulose layer.
Fig. 7. Fractionation of esterase incubated with ribose by a⁄n-
ity chromatography on A⁄-Gel 601. A = 0.1 M acetic acid;
B = 0.3 M acetic acid; C = 0.5 M acetic acid.
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in diabetic patients, experimental rats and the senile
cataractous lens [1,9^12,14]. Glycation-induced inac-
tivation of enzymes, which involves the reaction of a
reducible sugar with free N-terminal K-amino groups
or O-amino groups of lysine residues, is an important
factor in diabetic complications and cataracts. In the
results presented we show that carboxylesterase ac-
tivity was remarkably decreased by sugars of di¡er-
ent glycating abilities. Inactivation was more rapid in
the presence of ribose and fructose than G6P and
glucose which is consistent with previous studies of
other enzymes such as glutathione reductase, cata-
lase, superoxide dismutase, glucose 6-phosphate de-
hydrogenase and malate dehydrogenase [23].
During the inactivation of esterase by sugars, the
antibody precipitated similar amounts of activity as
the control, indicating that the inactivation of the
enzyme was paralleled by the loss of antigenicity.
The dot-blotting results demonstrated clearly that
the glycated esterase had entirely lost antigenicity,
again suggesting that inactivation of the enzyme
and its loss of antigenicity are simultaneous. Inacti-
vation of the enzyme could be by reaction of a mol-
ecule with its catalytic centre, or indirectly following
reaction elsewhere on the protein surface. The active
sites of enzymes often contain their most reactive
residues. The disruption of the surface charge net-
work of enzymes by glycation may result in confor-
mational changes which in turn lead to the progres-
sive loss of their catalytic activity and antigenicity.
The antigenicity might be lost through glycation of
the antigenic site itself or by glycation elsewhere
leading to a conformational change. The active site
of esterase might be partly similar to the antigenic
sites. However, enzyme activity may be compromised
before gross conformational changes of proteins take
place although inactivation can also be induced by
modi¢cation away from the active site.
Corticosteroids, often taken for prolonged periods
of time, are a risk factor for cataracts and systemic
disease. Enzyme levels fall during the onset of ster-
oid-induced cataracts [15,24]. P-21-H inactivated
catalase and glyceraldehyde 3-phosphate dehydro-
genase in vitro [25,26]. In the case of esterase, P-
21-H led to signi¢cant loss of enzyme activity during
9 days incubation. The activities precipitated by the
antibody are similar over 9 days except at time zero,
indicating that inactivation of esterase and loss of
antigenicity are simultaneous.
A signi¢cant association between inactivation and
loss of antigenicity of enzyme was identi¢ed. These
data, when considered with the previous evidence of
catalase and superoxide dismutase for inactivation
and loss antigenicity [20], indicate that glycation- or
steroid-induced inactivation of enzymes may contrib-
ute to the immunological di⁄culties of patients with
diabetes and age-related diseases.
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